Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain

Tubercle and Lung Disease

Volumn 79, Issue 3, 1999, Pages 187-190

  Gonzalez N ^a   Torres, M J ^a   Aznar, J ^a   Palomares, J C ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; NUCLEOTIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; GENE DELETION; GENE MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SPAIN; TUBERCULOSIS; ANTIBIOTIC RESISTANCE; DRUG EFFECT; GENETICS; HUMAN; MUTATION;

ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; HUMANS; ISONIAZID; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN;

EID: 0033254525     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1998.0195     Document Type: Article

References (24)

1. Heym B, Honoré N, Truffot-Pernot C. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet. 344:1994;293-298.
2. Musser J M. Antimicrobial resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev. 8:1995;496-514.
3. Zhang Y, Heym B, Allen B, Young D, Cole S T. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 358:1992;501-593.
4. Banerjee A, Dubnau E, Quemard A. InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 263:1994;227-230.
5. Mdluli K, Slayden R A, Zhu Y. Inhibition of Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isonizid. Science. 280:1998;1607-1610.
6. Wilson T M, Collins D M. AhpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol Microbiol. 19:1996;1025-1034.
7. Sherman D R, Mdluli K, Hickey M J. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science. 272:1996;1641-1643.
8. Vilanova, PA, USA, 1995.
9. Safi H, Aznar J, Palomares J C. Molecular epidemiology of Mycobacterium tuberculosis strains isolated during a 3-year period (1993-1995) in Seville, Spain. J Clin Microbiol. 35:1997;2472-2476.
10. Kent P T, Kubica G P. Public health mycobacteriology. A guide for the level III laboratory. PA: US Department of Health Service. Centers for Disease Control and Prevention. 1995;81-82.
11. Walsh P S, Metzger D A, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques. 10:1991;505-513.
12. Cooksey R C, Morlock G P, Glickman S, Crawford J T. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistantMycobacterium tuberculosis isolates from New York City. J Clin Microbiol. 35:1997;1281-1283.
13. Chaubert P, Bautista D, Benhattar J. An improved method for rapid screening of DNA mutations by non-radiactive single-strand conformation polymorphism procedure. BioTechniques. 15:1993;586.
14. Cockerill F R III, Uhl J R, Temesgen Z. Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. J Infect Dis. 171:1995;240-245.
15. Morris S, Han Bai G, Suffys P, Portillo-Gomez L, Fairchok M, Rouse D. Molecular mechanism of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis. 171:1995;954-960.
16. Telenti A, Honoré N, Bernasconi C. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol. 35:1997;719-723.
17. Kelley C L, Rouse D A, Morris S L. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 41:1997;2057-2058.
18. Nachamkin I, Kang C, Weinstein M P. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis. 24:1997;894-900.
19. Haas W H, Schilke K, Brand J. Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob Agents Chemother. 41:1997;1601-1603.
20. Heym B, Alzari P M, Honoré N, Cole S T. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance inMycobacterium tuberculosis. Mol Microbiol. 15:1995;235-245.
21. Kapur V, Li L-L, Hamrick M R. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antibiotic resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med. 119:1995;131-138.
22. Heym B, Alzari P M, Honore N, Cole S T. Overexpression, purification, and characterization of the catalase-peroxidase katG from Mycobacterium tuberculosis. J Biol Chem. 272:1997;2834-2840.
23. Khisimuzi M, Sherman D R, Hickey M J. Biochemical and genetic data suggest that inhA is not the primary target for activated isoniazid inMycobacterium tuberculosis. J Infect Dis. 174:1996;1085-1090.
24. Sreevatsan S, Pan X, Zhang Y, Deretic V, Musser J M. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother. 41:1997;600-606.